BOSTON, Dec. 18, 2018 /PRNewswire/ -- PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named OM1 as one of the most innovative Services of 2018.
Founded in 2015, OM1 is a health outcomes and technology company leveraging big clinical data, standardized outcome measurement, and artificial intelligence (AI) to better understand, compare, and predict patient outcomes.
OM1 was selected as part of PM360's 7th Annual Innovations Issue published each December. This issue was established to serve as a guide to the year's most innovative Companies, Startups, Divisions, Products, Services, and Strategies from within the healthcare and life sciences industries. This comprehensive overview of the year's most innovative achievements in these six categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.
"We are honored to be recognized by PM360 for our innovation. At OM1, we have lofty goals to fundamentally improve healthcare through a better understanding of real world results and through unprecedented insights into the relationships between care and outcomes and outcomes and value," said Dr. Richard Gliklich, CEO of OM1. "Our registries, platforms and technologies enable clients to accelerate research, to measure and benchmark health outcomes, and to personalize patient care in ways previously not possible."
PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360 evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, more than 60 total innovations were featured in the issue. Within the Startup category, a total of 8 startups were featured.
"Our selections represent the companies, offerings, and strategies that demonstrated what we believe to be unique in its ability to impact the industry," says Anna Stashower, CEO/Publisher of PM360. "We hope others in the industry are able to work with these innovators or use these innovations to better serve patients, physicians, and other healthcare stakeholders."
All of this year's selections can be found at: www.pm360online.com/pm360-presents-the-2018-innovators.
OM1 is a health outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes. OM1's real world evidence platform, clinical registries and AI technologies enable clients to accelerate research, measure and benchmark health outcomes and to personalize patient care.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal's targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the "360" in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.